Journal article
A Risk Model to Predict the Delivery of Adjuvant Chemotherapy Following Lung Resection in Patients With Pathologically Positive Lymph Nodes
Abstract
To investigate factors associated with the ability to receive adjuvant chemotherapy in patients with pathological N1 and N2 stage after anatomic lung resections for non-small cell lung cancer (NSCLC). Multicenter retrospective analysis on 707 consecutive patients found pathologic N1 (pN1) or N2 (pN2) disease following anatomic lung resections for NSCLC (2014-2019). Multiple imputation logistic regression was used to identify factors associated …
Authors
Patella M; Brunelli A; Adams L; Cafarotti S; Costardi L; De Leyn P; Decaluwé H; Franks KN; Fuentes M; Jimenez MF
Journal
Seminars in Thoracic and Cardiovascular Surgery, Vol. 35, No. 2, pp. 387–398
Publisher
Elsevier
Publication Date
2023
DOI
10.1053/j.semtcvs.2021.12.015
ISSN
1043-0679